(Q37872360)

24 August 2017

1 reference

title

Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example (English)

1 reference

24 August 2017

1 reference

R B Raffa

1

1 reference

PubMed ID

21545611

24 August 2017

J V Pergolizzi

series ordinal

2

1 reference

24 August 2017

19 October 2010

1 reference

Journal of Clinical Pharmacy and Therapeutics

24 August 2017

1 reference

24 August 2017

36

1 reference

24 August 2017

3

1 reference

24 August 2017

283-298

1 reference

Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The impact of pain management on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Chronic pain prevalence and analgesic prescribing in a general medical population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Adverse effects of systemic opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Anti-inflammatory and antinociceptive activities of an acid fraction of the seeds of Carpotroche brasiliensis (Raddi) (Flacourtiaceae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Antinociceptive activity of petroleum ether fraction from the MeOH extracts of Paederia scandens in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Hyperalgesic action in mice of intracerebroventricularly administered arachidonic acid, PG E2, PG F2 alpha and PG D2: effects of analgesic drugs on hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The palmitoylethanolamide family: a new class of anti-inflammatory agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Biosynthesis, degradation and pharmacological importance of the fatty acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

21 January 2018

Biosynthesis of oleamide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Oleamide synthesizing activity from rat kidney: identification as cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Amino acid and fatty acid composition of an aqueous extract of Channa striatus (Haruan) that exhibits antinociceptive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Effect of various antagonists on the Channa striatus fillet extract antinociception in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Influence of temperature, pH and naloxone on the antinociceptive activity of Channa striatus (haruan) extracts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Antinociceptive activity of Channa striatus (haruan) extracts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The abdominal constriction response and its suppression by analgesic drugs in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Total antioxidant capacity and malondialdehyde in acute abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

A role for free radicals and nitric oxide in delayed recovery in aged rats with chronic constriction nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Anti-inflammatory Activity of d-α-Tocopherol (Vitamin E) and Linoleic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Metabolism and function of skin lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Cellular injury by oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The anti-inflammatory effects of circulating fatty acids in obstructive jaundice: similarities with pregnancy-induced immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Glial activation: a driving force for pathological pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Muscarinic acetylcholine receptors: new potential therapeutic targets in antinociception and in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Modulation of pain transmission by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Targeting the cholinergic system as a therapeutic strategy for the treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Muscarinic-mediated analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Potassium channels and pain: present realities and future opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Inward rectifier potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The 'glibenclamide-shift' of centrally-acting antinociceptive agents in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Involvement of endogenous opioids and ATP-sensitive potassium channels in the mediation of carbachol-induced antinociception at the spinal level: a behavioral study in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Involvement of potassium channels in spinal antinociceptions induced by fentanyl, clonidine and bethanechol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

ATP-sensitive K+ channels are involved in the mediation of intrathecal norepinephrine- or morphine-induced antinociception at the spinal level: a study using EMG planimetry of flexor reflex in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

K+ channel openers activate brain sulfonylurea-sensitive K+ channels and block neurosecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

ATP-sensitive potassium channels mediate norepinephrine- and morphine-induced antinociception at the spinal cord level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by dipyrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Pharmacological evidence for the activation of K(+) channels by diclofenac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The NO-cGMP-K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Possible involvement of potassium channels in peripheral antinociception induced by metamizol: lack of participation of ATP-sensitive K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Participation of the L-arginine-nitric oxide-cyclic GMP-ATP-sensitive K+ channel cascade in the antinociceptive effect of rofecoxib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Mode of action of cannabinoids on nociceptive nerve endings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Cannabinoid type 2 receptor as a target for chronic - pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Role of cannabinoids in the management of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Therapeutic potential of cannabis in pain medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Endocannabinoid mechanisms of pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Therapeutic potential of cannabinoid receptor agonists as analgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The endogenous cannabinoid system and its role in nociceptive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Prospects for cannabinoids as anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Inhibition of pain responses by activation of CB(2) cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

21 January 2018

Cannabinoid analgesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Cannabinoid receptors and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Mechanisms underlying agonist efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Activation of G-proteins in brain by endogenous and exogenous cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The [35S]GTPγS binding assay: approaches and applications in pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Polyunsaturated fatty acids are potent neuroprotectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Acid-sensitive ion channels and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Transient receptor potential channels on sensory nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Structure and function of TRPV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Signal transduction activated by cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The vanilloid receptor as a putative target of diverse chemicals in multiple chemical sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Forty years in capsaicin research for sensory pharmacology and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Biochemical pharmacology of the vanilloid receptor TRPV1. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

TRPV channels as temperature sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The cloned capsaicin receptor integrates multiple pain-producing stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

Roles of transient receptor potential channels in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

TRPV1 is a novel target for omega-3 polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2010.01190.X

10.1111/J.1365-2710.2010.01190.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21545611